Articles on key issues related to the pharma industry from the heads of leading pharmaceutical companies and pharma industry experts across the globe. The pharma industry articles' section focuses on current and emerging issues in areas such as Strategic developments in the pharma industry, pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical manufacturing, biopharmaceuticals, and information technology.
Since seminal work by Dr Mitra from Tata Medical Centre has been done on Cellfree chromatin particles that are released upon cell death When cancer cells die the skeletons of mutated cell free
Cancer is the most prevalent cause of death across the globe According to the World Health Organization there is an estimated increase from the anticipated million cases of cancer in It is predicted that more than million
A radiopharmaceutical is a radioactive compound used for the diagnosis and treatment of human diseases In nuclear medicine nearly of the radiopharmaceuticals are used for diagnostic purposes while the rest are used for treatment It is a relatively new modality
CIS are syringelike cellpuncturing machines Bacteria deploy it for various natural functions including cellcell communications defence and in endosymbionts to interact with the hosts CIS translocate effectors molecules
Radiation therapy chemotherapy and surgery have been the cornerstones of cancer treatment for many years While they remain essential therapy pillars recent advancements in the field have significantly changed the treatment landscape for cancer patients
In our constantly changing world healthcare is an essential element of growth Pursuing safer more effective healthcare solutions has led to innovative strategies transforming the industry
Cancer is considered as a common name to address a large group comprising more than diseases affecting several parts of the body All cancers show common characteristics such as the uncontrolled growth and proliferation of abnormal cells
In the complex landscape of Pharmacy Benefit Management PBM combatting Fraud Waste and Abuse FWA has emerged as a critical challenge This article explores innovative realtime techniques for PBMs to navigate the intricacies of FWA and Medicare noncompliance
In an era where medical science is advancing at an unprecedented pace the integration of bioinformatics has emerged as a gamechanger offering new avenues for understanding diagnosing and treating cancer
India is rapidly emerging as a global hub for clinical research with many international pharmaceutical companies and research organisations choosing the country as a site for their clinical trials
